Citations

Clear

35 citation(s) found for "Tremaine, W J".

Domain-specific physical activity and mental health: an updated systematic review and multilevel meta-analysis in a combined sample of 3.3 million people
Sousa, Geovan Menezes de , Baker, Thea , Liddelow, Caitlin , Babic, Mark , France‐Ratcliffe, Madeleine , Guagliano, Justin M. , Tremaine, Ella M , Booker, Bridget , Gargioli, Davide , Bannell, Daniel J , Bao, Ran , Brooks, Cristy , Vella, Stewart A. , Lonsdale, Chris , Teychenne, Megan , Sousa, Geovan M , Liddelow, Caitlin , Christie, Hannah E. , Lubans, David R , Swann, Christian , Vella, Stewart A , Lonsdale, Chris , White, Rhiannon L , Chauntry, Aiden J. , Santos, Alexandre

Mayo Clinic

British Journal of Sports Medicine | September 3, 2025 | Volume: 60 | Issue: 4 | Pages: 267-285

10.1136/bjsports-2025-109806 | PMID 40903203 Get It

Objective To update, synthesise and provide meta-analytical evidence of the associations between domain-specific physical activity (PA) and mental health and mental ill-health outcomes. Design Systematic review and multilevel meta-analysis. Data sources In March 2024, we systematically searched five databases. Eligibility criteria Methods employed replicated those of a previous review in 2017. All studies examining associations between domain-specific PA and specified mental health outcomes were included. Results 372 studies met inclusion criteria and 361 were included in the meta-analysis. Across the 372 studies (combined sample size of 3 323 711), 338 examined leisure-time PA, 54 work-related PA, 72 transport-related PA, 44 household PA, 5 school sport and 8 physical education. Multilevel meta-analyses showed that leisure-time PA (r=0.205, 95% CI 0.157 to 0.253), transport-related PA (r=0.138, 95% CI 0.042 to 0.231) and household PA (r=0.096, 95% CI 0.025 to 0.165) were positively associated with mental health . Leisure-time PA (r=−0.149, 95% CI −0.189 to –0.11) and school sport (r=−0.096, 95% CI −0.115 to –0.077) were inversely associated with mental ill health . However, work-related PA (r=0.134 95% CI 0.069 to 0.199) was positively associated with mental ill health . Conclusion The direction of the association between PA and mental health/mental ill health is dependent on the domain in which PA occurs. Promoting PA for leisure purposes is likely to yield the greatest benefits for both promoting mental health and preventing mental ill health. As such, leisure-time PA should be prioritised in messaging, guidelines and interventions/programmes designed to support mental health through PA. PROSPERO registration number CRD42024510303.
S976 Contemporary Sociodemographic and Regional Differences Among Hospitalized Patients With Inflammatory Bowel Diseases in the United States
Pemmasani, Gayatri , Tremaine, William J., Loftus, Edward V.

Mayo Clinic

American Journal of Gastroenterology | October 18, 2023 | Volume: 118 | Issue: 10S | Pages: S736-S737

10.14309/01.ajg.0000953544.06582.08 Get It

S244 Open Label Experience With Bismuth Subsalicylate in Patients With Microscopic Colitis
Pardi, Ryan, Tremaine, William J., Khanna, Sahil , Pardi, Darrell S. , Tariq, Raseen , Loftus, Edward V. , Saha, Srishti

Mayo Clinic

American Journal of Gastroenterology | October 18, 2023 | Volume: 118 | Issue: 10S | Pages: S183-S183

10.14309/01.ajg.0000950616.02611.e6 Get It

Sex differences in clinical characteristics and outcomes associated with alcoholic hepatitis
Pemmasani, Gayatri , Tremaine, William J., Aswath, Ganesh, Sapkota, Bishnu, Karagozian, Raffi, John, Savio, Kumar, Vishnu Charan Suresh

Mayo Clinic

European Journal of Gastroenterology & Hepatology | August 14, 2023 | Volume: 35 | Issue: 10 | Pages: 1192-1196

10.1097/meg.0000000000002612 | PMID 37577797 Get It

Background Alcohol-associated liver disease is increasing among females with an earlier onset and more severe disease at lower levels of exposure. However, there is paucity of literature regarding sex differences related to alcoholic hepatitis. Methods Hospitalized patients with alcoholic hepatitis were selected from the US Nationwide readmissions database 2019. In this cohort, we evaluated sex differences in baseline comorbidities, alcoholic hepatitis related complications and mortality. A subset of patients with alcoholic hepatitis who were hospitalized between January and June 2019 were identified to study sex differences in 6 month readmission rate, mortality during readmission, and composite of mortality during index hospitalization or readmission. Results Among 112 790 patients with alcoholic hepatitis, 33.3% were female. Female patients were younger [48 (38–57) vs. 49 (39–58) years; both P < 0.001] but had higher rates of important medical and mental-health related comorbidities. Compared with males, females had higher rates of hepatic encephalopathy (11.5% vs. 10.1; P < 0.001), ascites (27.9% vs. 22.5%; P < 0.001), portal hypertension (18.5% vs. 16.4%; P < 0.001), cirrhosis (37.3% vs. 31.9%; P < 0.001), weight loss (19.0% vs. 14.5%; P < 0.001), hepatorenal syndrome (4.4% vs. 3.8%; P < 0.001), spontaneous bacterial peritonitis (1.9% vs. 1.7%; P = 0.026), sepsis (11.1% vs. 9.5%; P < 0.001), and blood transfusion (12.9% vs. 8.7%; P < 0.001). Females had a similar in-hospital mortality rate (4.3%) compared to males (4.1%; P = 0.202; adjusted odds ratio (OR) 1.02, 95% CI (cardiac index) 0.89–1.15; P = 0.994). In the subset of patients (N = 58 688), females had a higher 6-month readmission rate (48.9% vs. 44.9%; adjusted OR 1.12 (1.06–1.18); P < 0.001), mortality during readmission (4.4% vs. 3.2%; OR 1.23 (1.08–1.40); P < 0.01), and composite of mortality during index hospitalization or readmission (8.7% vs. 7.2%; OR 1.15 (1.04–1.27); P < 0.01). Conclusion Compared to their male counterparts, females with alcoholic hepatitis were generally younger but had higher rates of comorbidities, alcoholic hepatitis related complications, rehospitalizations and associated mortality. The greater risks of alcohol-associated liver dysfunction in females indicate the need for more aggressive management.
Prevalence and Impact of Obesity in a Population-Based Cohort of Patients With Crohn’s Disease
Johnson, Amanda M. , Harmsen, William S. , Tremaine, William J., Raffals, Laura E. , Harmsen, William Scott, Aniwan, Satimai , Dayyeh, Barham K. Abu , Loftus, Edward V.

Mayo Clinic

Journal of Clinical Gastroenterology | February 2, 2023 | Volume: 58 | Issue: 2 | Pages: 176-182

10.1097/mcg.0000000000001821 | PMID 36728679 Get It

Background: Obesity is on the rise within the inflammatory bowel disease population. The impact obesity has on the natural history of Crohn’s disease (CD) is not well-understood. We aimed to describe the prevalence of obesity in a population-based cohort of newly diagnosed patients with CD, and the impact obesity had on disease phenotype and outcomes of corticosteroid use, hospitalization, intestinal resection, and development of fistulizing or penetrating disease. Materials and Methods: A chart review was performed on Olmsted County, Minnesota residents diagnosed with CD between 1970 and 2010. Data were collected on demographics, body mass index, CD location and behavior, CD-related hospitalizations, corticosteroid use, and intestinal resection. The proportion of individuals considered obese at the time of CD diagnosis was evaluated over time, and CD-associated complications were assessed with Kaplan-Meier survival analysis. Results: We identified 334 individuals diagnosed with CD between 1970 and 2010, of whom 156 (46.7%) were either overweight (27.8%) or obese (18.9%) at the time of diagnosis. The proportion of patients considered obese at the time of their diagnosis of CD increased 2-3 fold over the course of the study period. However, obesity did not have a significant impact on the future risk of corticosteroid use, hospitalization, intestinal resection, or development of penetrating and stricturing complications. Conclusions: Obesity is on the rise in patients with CD, although in this cohort, there did not appear to be any negative association with future CD-related outcomes. Further prospective studies, ideally including obesity measures such as visceral adipose tissue assessment, are warranted to understand the implications of the rising prevalence of obesity on CD outcomes.
Osteonecrosis in Inflammatory Bowel Disease: Clinical Features, Risk Factor Analysis, and Outcomes
Bakhshi, Zeinab , Yadav, Siddhant, Harmsen, William S. , Varayil, Jithinraj Edakkanambeth , Karls, Kevin A, Tremaine, William J., Loftus, Edward V. , Edakkanambeth Varayil, Jithinraj, Loftus, Edward V , Edakkanambeth Varayil, Jithinraj , Karls, Kevin A.

Mayo Clinic

Inflammatory Bowel Diseases | September 23, 2022 | Volume: 29 | Issue: 8 | Pages: 1223-1230

10.1093/ibd/izac198 | PMID 36149260 Get It

AbstractBackgroundAvascular necrosis (AVN) is a known adverse event associated with corticosteroid (CS) usage. Inflammatory bowel disease (IBD) is often treated with a CS for induction of remission. We sought to describe clinical features and outcomes of IBD patients with AVN.MethodsIn this retrospective, single-center, case-control study, patients with IBD who had a diagnosis of osteonecrosis, aseptic necrosis, or AVN from 1976 to 2009 were included, and each was matched with up to 2 controls (IBD but no AVN) on age, sex, IBD subtype, geographic area of residence, and date of IBD diagnosis. We abstracted risk factor data from the medical records. Conditional logistic regression was performed accounting for minor differences in age and date of first IBD visit to assess the relationship between putative risk factors and AVN, expressed as odds ratio and 95% confidence interval.ResultsEighty-five patients were diagnosed with IBD-AVN and were matched with 163 controls. The mean age at AVN diagnosis was 47.5 years. AVN was diagnosed a median of 12.2 years after IBD diagnosis, and the control group was followed for a median of 15 years after IBD diagnosis to ensure that they did not have AVN. Ten percent of patients with AVN did not have any CS exposure. History of arthropathy or estrogen use in Crohn’s disease and use of CS, osteoporosis, and history of arthropathy in ulcerative colitis were significantly associated with AVN.ConclusionsMost patients with IBD-AVN had multifocal involvement. Most had received CS, but many patients had other risk factors including arthropathy.
A Cohort Study of the Age at Menopause in Female Patients With and Without Inflammatory Bowel Disease
Moktan, Varun , Daoud, Nader , Tremaine, William J., Kane, Sunanda V. , Hochwald, Alexander , Hodge, David O. , Farraye, Francis A. , Kane, S , Hochwald, Alexander P, Farraye, Francis A , Loftus, Edward V. , Hashash, Jana G. , Faubion, Stephanie S.

Mayo Clinic

Crohn's & Colitis 360 | August 4, 2022 | Volume: 4 | Issue: 3 | Pages: No page available

10.1093/crocol/otac027 | PMID 36045902 Get It

Abstract Background Menopause, defined by the complete cessation of menstrual cycles for 12 consecutive months, may occur at a younger age in women who have concomitant immune dysregulation. Our aim was to determine whether women with inflammatory bowel disease (IBD) experience an earlier onset of menopause compared to women without IBD. Methods This was a retrospective cohort study using resources of the Rochester Epidemiology Project, a collaboration between clinics, hospitals, and medical facilities in Olmsted County, Minnesota. From these people, women who were diagnosed with IBD between 1970 and 2010 comprised the case cohort while the reference cohort included women with no diagnosis of IBD. Data including age, body mass index (BMI), ethnicity, smoking status, age at onset of menopause, and current use of hormone therapy were collected. Patients with history of hysterectomy or oophorectomy were excluded. Wilcoxon rank-sum test for numeric variables and Fisher’s exact test for categorical variables were used to analyze the data. Results A total of 171 women met criteria for inclusion (83 cases and 88 controls). Mean age of menopause in women with IBD was 50.0 years compared to 51.5 years in women with no IBD (P = .006). There was no difference in BMI of women with and without IBD (28.7 versus 28.2 kg m−2; P = .9), respectively. There were more former smokers (33.7%) and current (6%) smokers in the IBD group (P = .009) compared to the non-IBD group. Conclusions IBD is associated with an earlier onset of menopause. Although it is unclear if this mean difference of 1.5 years is clinically relevant, it is known that early menopause is associated with an increased risk of osteoporosis and cardiovascular disease. Further research on the possible mechanisms is needed.
S958 Pharmacogene CYP1A2*1F Polymorphism Lowers Anti-TNF (infliximab) Response in Inflammatory Bowel Disease Patients
Wang, Ming‐Hsi , Timmons, Lawrence J., Koop, Andree , Tremaine, William J.

Mayo Clinic

American Journal of Gastroenterology | October 24, 2021 | Volume: 116 | Issue: 1 | Pages: S458-S458

10.14309/01.ajg.0000777364.76967.26 Get It

S778 A Cross-Sectional Evaluation of the Prevalence of Pulmonary Diseases in Patients With Inflammatory Bowel Disease
Pemmasani, Gayatri , Tremaine, William J., Loftus, Edward V.

Mayo Clinic

American Journal of Gastroenterology | October 24, 2021 | Volume: 116 | Issue: 1 | Pages: S360-S361

10.14309/01.ajg.0000776644.58292.96 Get It

S763 A Cohort Study of the Age of Menopause in Female Patients With and Without Inflammatory Bowel Disease
Moktan, Varun , Daoud, Nader , Tremaine, William J., Kane, Sunanda V. , Hochwald, Alexander , Hodge, David O. , Loftus, Edward V. , Faubion, Stephanie S. , Farraye, Francis A.

Mayo Clinic

American Journal of Gastroenterology | October 24, 2021 | Volume: 116 | Issue: 1 | Pages: S352-S353

10.14309/01.ajg.0000776584.48281.9f Get It